FENNEC PHARMACEUTICALS INC. (FENC) Total liabilities 2016–2025
FENNEC PHARMACEUTICALS INC. (FENC) total liabilities at each fiscal year-end, per SEC filings.
$35.1MFY2025 · since FY2016: $402,000 → $35.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.1M | -31.0% |
| FY2024 | $50.8M | +32.0% |
| FY2023 | $38.5M | +30.4% |
| FY2022 | $29.5M | — |
| FY2020 | $2.3M | +3.3% |
| FY2019 | $2.3M | +38.7% |
| FY2018 | $1.6M | -0.4% |
| FY2017 | $1.6M | +309.0% |
| FY2016 | $402,000 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More FENC financial trends
FENC RevenueFENC Net incomeFENC Net marginFENC Gross profitFENC Gross marginFENC Operating incomeFENC Operating marginFENC Operating cash flowFENC Free cash flowFENC Capital expendituresFENC Return on equityFENC Stock buybacksFENC Dividends paidFENC Total assetsFENC Shareholders’ equityFENC overview →